Brooks WH, , Markesbery WR, & Gupta GD, et al: Relationship of lymphocyte invasion and survival of brain tumor patients. Ann Neurol 4:219–224, 1978 Brooks WH, Markesbery WR, Gupta GD, et al: Relationship of lymphocyte invasion and survival of brain tumor patients. Ann Neurol 4:219–224, 1978

Brooks WH, Markesbery WR, Gupta GD, et al: Relationship of lymphocyte invasion and survival of brain tumor patients. Ann Neurol 4:219–224, 1978Brooks WH, Markesbery WR, Gupta GD, et al: Relationship of lymphocyte invasion and survival of brain tumor patients. Ann Neurol 4:219–224, 1978)| false
• Search Google Scholar
• Export Citation

Brooks WH, , Netsky MG, & Normansell DE, et al: Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor. J Exp Med 136:1631–1647, 1972 Brooks WH, Netsky MG, Normansell DE, et al: Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor. J Exp Med 136:1631–1647, 1972

Brooks WH, Netsky MG, Normansell DE, et al: Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor. J Exp Med 136:1631–1647, 1972Brooks WH, Netsky MG, Normansell DE, et al: Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor. J Exp Med 136:1631–1647, 1972)| false
• Search Google Scholar
• Export Citation

Coakham HB, , Kornblith PL, & Quindlen EA, et al: Autologous humoral response to human gliomas and analysis of certain cell surface antigens: in vitro study with the use of microcytotoxicity and immune adherence assays. JNCI 64:223–233, 1980 Coakham HB, Kornblith PL, Quindlen EA, et al: Autologous humoral response to human gliomas and analysis of certain cell surface antigens: in vitro study with the use of microcytotoxicity and immune adherence assays. JNCI 64:223–233, 1980

Coakham HB, Kornblith PL, Quindlen EA, et al: Autologous humoral response to human gliomas and analysis of certain cell surface antigens: in vitro study with the use of microcytotoxicity and immune adherence assays. JNCI 64:223–233, 1980Coakham HB, Kornblith PL, Quindlen EA, et al: Autologous humoral response to human gliomas and analysis of certain cell surface antigens: in vitro study with the use of microcytotoxicity and immune adherence assays. JNCI 64:223–233, 1980)| false
• Search Google Scholar
• Export Citation

Danielpour D, & Sporn MB: Differential inhibition of transforming growth factor β1 and β2 activity by α2-macroglobulin. J Biol Chem 265:6973–6977, 1990 Danielpour D, Sporn MB: Differential inhibition of transforming growth factor β1 and β2 activity by α2-macroglobulin. J Biol Chem 265:6973–6977, 1990

Danielpour D, Sporn MB: Differential inhibition of transforming growth factor β1 and β2 activity by α₂-macroglobulin. J Biol Chem 265:6973–6977, 1990Danielpour D, Sporn MB: Differential inhibition of transforming growth factor β1 and β2 activity by α₂-macroglobulin. J Biol Chem 265:6973–6977, 1990)| false
• Search Google Scholar
• Export Citation

de Martin R, , Haendler B, & Hofer-Warbinek R, et al: Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-β gene family. EMBO J 6:3673–3677, 1987 de Martin R, Haendler B, Hofer-Warbinek R, et al: Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-β gene family. EMBO J 6:3673–3677, 1987

de Martin R, Haendler B, Hofer-Warbinek R, et al: Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-β gene family. EMBO J 6:3673–3677, 1987de Martin R, Haendler B, Hofer-Warbinek R, et al: Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-β gene family. EMBO J 6:3673–3677, 1987)| false
• Search Google Scholar
• Export Citation

de Muralt B, , de Tribolet N, & Diserens AC, et al: Phenotyping of 60 cultured human gliomas and 34 other neuroectodermal tumors by means of monoclonal antibodies against glioma, melanoma and HLA-DR antigens. Eur J Cancer Clin Oncol 21:207–216, 1985 de Muralt B, de Tribolet N, Diserens AC, et al: Phenotyping of 60 cultured human gliomas and 34 other neuroectodermal tumors by means of monoclonal antibodies against glioma, melanoma and HLA-DR antigens. Eur J Cancer Clin Oncol 21:207–216, 1985

de Muralt B, de Tribolet N, Diserens AC, et al: Phenotyping of 60 cultured human gliomas and 34 other neuroectodermal tumors by means of monoclonal antibodies against glioma, melanoma and HLA-DR antigens. Eur J Cancer Clin Oncol 21:207–216, 1985de Muralt B, de Tribolet N, Diserens AC, et al: Phenotyping of 60 cultured human gliomas and 34 other neuroectodermal tumors by means of monoclonal antibodies against glioma, melanoma and HLA-DR antigens. Eur J Cancer Clin Oncol 21:207–216, 1985)| false
• Search Google Scholar
• Export Citation

Espevik T, , Figari IS, & Shalaby MR, et al: Inhibition of cytokine production by cyclosporin A and transforming growth factor β. J Exp Med 166:571–576, 1987 Espevik T, Figari IS, Shalaby MR, et al: Inhibition of cytokine production by cyclosporin A and transforming growth factor β. J Exp Med 166:571–576, 1987

Espevik T, Figari IS, Shalaby MR, et al: Inhibition of cytokine production by cyclosporin A and transforming growth factor β. J Exp Med 166:571–576, 1987Espevik T, Figari IS, Shalaby MR, et al: Inhibition of cytokine production by cyclosporin A and transforming growth factor β. J Exp Med 166:571–576, 1987)| false
• Search Google Scholar
• Export Citation

Fontana A, , Hengartner H, & de Tribolet N, et al: Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects. J Immunol 132:1837–1844, 1984 Fontana A, Hengartner H, de Tribolet N, et al: Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects. J Immunol 132:1837–1844, 1984

Fontana A, Hengartner H, de Tribolet N, et al: Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects. J Immunol 132:1837–1844, 1984Fontana A, Hengartner H, de Tribolet N, et al: Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects. J Immunol 132:1837–1844, 1984)| false
• Search Google Scholar
• Export Citation

Gately MK, , Glaser M, & Dick SJ, et al: In vitro studies on the cell-mediated immune response to human brain tumors. I. Requirement for third-party stimulator lymphocytes in the induction of cell-mediated cytotoxic responses to allogenic cultured gliomas. JNCI 69:1245–1254, 1982 Gately MK, Glaser M, Dick SJ, et al: In vitro studies on the cell-mediated immune response to human brain tumors. I. Requirement for third-party stimulator lymphocytes in the induction of cell-mediated cytotoxic responses to allogenic cultured gliomas. JNCI 69:1245–1254, 1982

Gately MK, Glaser M, Dick SJ, et al: In vitro studies on the cell-mediated immune response to human brain tumors. I. Requirement for third-party stimulator lymphocytes in the induction of cell-mediated cytotoxic responses to allogenic cultured gliomas. JNCI 69:1245–1254, 1982Gately MK, Glaser M, Dick SJ, et al: In vitro studies on the cell-mediated immune response to human brain tumors. I. Requirement for third-party stimulator lymphocytes in the induction of cell-mediated cytotoxic responses to allogenic cultured gliomas. JNCI 69:1245–1254, 1982)| false
• Search Google Scholar
• Export Citation

Hanks SK, , Armour R, & Baldwin JH, et al: Amino acid sequence of the BSC-1 cell growth inhibitor (polyergin) deduced from the nucleotide sequence of the cDNA. Proc Natl Acad Sci USA 85:79–82, 1988 Hanks SK, Armour R, Baldwin JH, et al: Amino acid sequence of the BSC-1 cell growth inhibitor (polyergin) deduced from the nucleotide sequence of the cDNA. Proc Natl Acad Sci USA 85:79–82, 1988

Hanks SK, Armour R, Baldwin JH, et al: Amino acid sequence of the BSC-1 cell growth inhibitor (polyergin) deduced from the nucleotide sequence of the cDNA. Proc Natl Acad Sci USA 85:79–82, 1988Hanks SK, Armour R, Baldwin JH, et al: Amino acid sequence of the BSC-1 cell growth inhibitor (polyergin) deduced from the nucleotide sequence of the cDNA. Proc Natl Acad Sci USA 85:79–82, 1988)| false
• Search Google Scholar
• Export Citation

Hoefler H, , Childers H, & Montminy MR, et al: In situ hybridization methods for the detection of somatostatin mRNA in tissue sections using antisense RNA probes. Histochem J 18:597–604, 1986 Hoefler H, Childers H, Montminy MR, et al: In situ hybridization methods for the detection of somatostatin mRNA in tissue sections using antisense RNA probes. Histochem J 18:597–604, 1986

Hoefler H, Childers H, Montminy MR, et al: In situ hybridization methods for the detection of somatostatin mRNA in tissue sections using antisense RNA probes. Histochem J 18:597–604, 1986Hoefler H, Childers H, Montminy MR, et al: In situ hybridization methods for the detection of somatostatin mRNA in tissue sections using antisense RNA probes. Histochem J 18:597–604, 1986)| false
• Search Google Scholar
• Export Citation

Kanzaki T, , Olofsson A, & Morén A, et al: TGF-β1 binding protein: a component of the large latent complex of TGF-β1 with multiple repeat sequences. Cell 61:1051–1061, 1990 Kanzaki T, Olofsson A, Morén A, et al: TGF-β1 binding protein: a component of the large latent complex of TGF-β1 with multiple repeat sequences. Cell 61:1051–1061, 1990

Kanzaki T, Olofsson A, Morén A, et al: TGF-β1 binding protein: a component of the large latent complex of TGF-β1 with multiple repeat sequences. Cell 61:1051–1061, 1990Kanzaki T, Olofsson A, Morén A, et al: TGF-β1 binding protein: a component of the large latent complex of TGF-β1 with multiple repeat sequences. Cell 61:1051–1061, 1990)| false
• Search Google Scholar
• Export Citation

Kehrl JH, , Roberts AB, & Wakefield LM, et al: Transforming growth factor β is an important immunomodulatory protein for human B lymphocytes. J Immunol 137:3855–3860, 1986 Kehrl JH, Roberts AB, Wakefield LM, et al: Transforming growth factor β is an important immunomodulatory protein for human B lymphocytes. J Immunol 137:3855–3860, 1986

Kehrl JH, Roberts AB, Wakefield LM, et al: Transforming growth factor β is an important immunomodulatory protein for human B lymphocytes. J Immunol 137:3855–3860, 1986Kehrl JH, Roberts AB, Wakefield LM, et al: Transforming growth factor β is an important immunomodulatory protein for human B lymphocytes. J Immunol 137:3855–3860, 1986)| false
• Search Google Scholar
• Export Citation

Kehrl JH, , Wakefield LM, & Roberts AB, et al: Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 163:1037–1050, 1986 Kehrl JH, Wakefield LM, Roberts AB, et al: Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 163:1037–1050, 1986

Kehrl JH, Wakefield LM, Roberts AB, et al: Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 163:1037–1050, 1986Kehrl JH, Wakefield LM, Roberts AB, et al: Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 163:1037–1050, 1986)| false
• Search Google Scholar
• Export Citation

Kikuchi K, & Neuwelt EA: Presence of immunosuppressive factors in brain-tumor cyst fluid. J Neurosurg 59:790–799, 1983 Kikuchi K, Neuwelt EA: Presence of immunosuppressive factors in brain-tumor cyst fluid. J Neurosurg 59:790–799, 1983

Kikuchi K, Neuwelt EA: Presence of immunosuppressive factors in brain-tumor cyst fluid. J Neurosurg 59:790–799, 1983Kikuchi K, Neuwelt EA: Presence of immunosuppressive factors in brain-tumor cyst fluid. J Neurosurg 59:790–799, 1983)| false
• Search Google Scholar
• Export Citation

Kuppner MC, , Hamou MF, & Bodmer S, et al: The glioblastoma-derived T-cell suppressor factor/transforming growth factor beta2 inhibits the generation of lymphokine-activated killer (LAK) cells. Int J Cancer 42:562–567, 1988 Kuppner MC, Hamou MF, Bodmer S, et al: The glioblastoma-derived T-cell suppressor factor/transforming growth factor beta2 inhibits the generation of lymphokine-activated killer (LAK) cells. Int J Cancer 42:562–567, 1988

Kuppner MC, Hamou MF, Bodmer S, et al: The glioblastoma-derived T-cell suppressor factor/transforming growth factor beta₂ inhibits the generation of lymphokine-activated killer (LAK) cells. Int J Cancer 42:562–567, 1988Kuppner MC, Hamou MF, Bodmer S, et al: The glioblastoma-derived T-cell suppressor factor/transforming growth factor beta₂ inhibits the generation of lymphokine-activated killer (LAK) cells. Int J Cancer 42:562–567, 1988)| false
• Search Google Scholar
• Export Citation

Laiho M, , De Caprio JA, & Ludlow JW, et al: Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell 62:175–185, 1990 Laiho M, De Caprio JA, Ludlow JW, et al: Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell 62:175–185, 1990

Laiho M, De Caprio JA, Ludlow JW, et al: Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell 62:175–185, 1990Laiho M, De Caprio JA, Ludlow JW, et al: Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell 62:175–185, 1990)| false
• Search Google Scholar
• Export Citation

Lewis SA, , Balcarek J, & Krek V, et al: Sequence of a cDNA encoding mouse glial fibrillary acidic protein: structural conservation of intermediate filaments. Proc Natl Acad Sci USA 81:2743–2746, 1984 Lewis SA, Balcarek J, Krek V, et al: Sequence of a cDNA encoding mouse glial fibrillary acidic protein: structural conservation of intermediate filaments. Proc Natl Acad Sci USA 81:2743–2746, 1984

Lewis SA, Balcarek J, Krek V, et al: Sequence of a cDNA encoding mouse glial fibrillary acidic protein: structural conservation of intermediate filaments. Proc Natl Acad Sci USA 81:2743–2746, 1984Lewis SA, Balcarek J, Krek V, et al: Sequence of a cDNA encoding mouse glial fibrillary acidic protein: structural conservation of intermediate filaments. Proc Natl Acad Sci USA 81:2743–2746, 1984)| false
• Search Google Scholar
• Export Citation

Maxwell M, , Nabor SP, & Wolfe HJ, et al: Coexpression of platelet-derived growth factor (PDGF) and PDGF-receptor genes by primary human astrocytomas may contribute to their development and maintenance. J Clin Invest 86:131–140, 1990 Maxwell M, Nabor SP, Wolfe HJ, et al: Coexpression of platelet-derived growth factor (PDGF) and PDGF-receptor genes by primary human astrocytomas may contribute to their development and maintenance. J Clin Invest 86:131–140, 1990

Maxwell M, Nabor SP, Wolfe HJ, et al: Coexpression of platelet-derived growth factor (PDGF) and PDGF-receptor genes by primary human astrocytomas may contribute to their development and maintenance. J Clin Invest 86:131–140, 1990Maxwell M, Nabor SP, Wolfe HJ, et al: Coexpression of platelet-derived growth factor (PDGF) and PDGF-receptor genes by primary human astrocytomas may contribute to their development and maintenance. J Clin Invest 86:131–140, 1990)| false
• Search Google Scholar
• Export Citation

Maxwell M, , Nabor SP, & Wolfe HJ, et al: Expression of angiogenic growth factor genes in primary human astrocytomas may contribute to their growth and progression. Cancer Res 51:1345–1351, 1991 Maxwell M, Nabor SP, Wolfe HJ, et al: Expression of angiogenic growth factor genes in primary human astrocytomas may contribute to their growth and progression. Cancer Res 51:1345–1351, 1991

Maxwell M, Nabor SP, Wolfe HJ, et al: Expression of angiogenic growth factor genes in primary human astrocytomas may contribute to their growth and progression. Cancer Res 51:1345–1351, 1991Maxwell M, Nabor SP, Wolfe HJ, et al: Expression of angiogenic growth factor genes in primary human astrocytomas may contribute to their growth and progression. Cancer Res 51:1345–1351, 1991)| false
• Search Google Scholar
• Export Citation

McPherson JM, , Sawamura SJ, & Ogawa Y, et al: The growth inhibitor of African green monkey (BSC-1) cells in transforming growth factors β1 and β2. Biochemistry 28:3442–3447, 1989 McPherson JM, Sawamura SJ, Ogawa Y, et al: The growth inhibitor of African green monkey (BSC-1) cells in transforming growth factors β1 and β2. Biochemistry 28:3442–3447, 1989

McPherson JM, Sawamura SJ, Ogawa Y, et al: The growth inhibitor of African green monkey (BSC-1) cells in transforming growth factors β1 and β2. Biochemistry 28:3442–3447, 1989McPherson JM, Sawamura SJ, Ogawa Y, et al: The growth inhibitor of African green monkey (BSC-1) cells in transforming growth factors β1 and β2. Biochemistry 28:3442–3447, 1989)| false
• Search Google Scholar
• Export Citation

Miescher S, , Whiteside TL, & Carrel S, et al: Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: effects of tumor cells and their supernatants on proliferative responses of lymphocytes. J Immunol 136:1899–1907, 1986 Miescher S, Whiteside TL, Carrel S, et al: Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: effects of tumor cells and their supernatants on proliferative responses of lymphocytes. J Immunol 136:1899–1907, 1986

Miescher S, Whiteside TL, Carrel S, et al: Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: effects of tumor cells and their supernatants on proliferative responses of lymphocytes. J Immunol 136:1899–1907, 1986Miescher S, Whiteside TL, Carrel S, et al: Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: effects of tumor cells and their supernatants on proliferative responses of lymphocytes. J Immunol 136:1899–1907, 1986)| false
• Search Google Scholar
• Export Citation

Palma L, , Di Lorenzo N, & Guidetti B: Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas. Incidence, fate, and relevance to prognosis in 228 operated cases. J Neurosurg 49:854–861, 1978 Palma L, Di Lorenzo N, Guidetti B: Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas. Incidence, fate, and relevance to prognosis in 228 operated cases. J Neurosurg 49:854–861, 1978

Palma L, Di Lorenzo N, Guidetti B: Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas. Incidence, fate, and relevance to prognosis in 228 operated cases. J Neurosurg 49:854–861, 1978Palma L, Di Lorenzo N, Guidetti B: Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas. Incidence, fate, and relevance to prognosis in 228 operated cases. J Neurosurg 49:854–861, 1978)| false
• Search Google Scholar
• Export Citation

Pietenpol JA, , Stein RW, & Moran E, et al: TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell 61:777–785, 1990 Pietenpol JA, Stein RW, Moran E, et al: TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell 61:777–785, 1990

Pietenpol JA, Stein RW, Moran E, et al: TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell 61:777–785, 1990Pietenpol JA, Stein RW, Moran E, et al: TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell 61:777–785, 1990)| false
• Search Google Scholar
• Export Citation

Ponte P, , Ng SY, & Engel J, et al: Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA. Nucleic Acid Res 12:1687–1696, 1984 Ponte P, Ng SY, Engel J, et al: Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA. Nucleic Acid Res 12:1687–1696, 1984

Ponte P, Ng SY, Engel J, et al: Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA. Nucleic Acid Res 12:1687–1696, 1984Ponte P, Ng SY, Engel J, et al: Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA. Nucleic Acid Res 12:1687–1696, 1984)| false
• Search Google Scholar
• Export Citation

Pulver M, , Zuber P, & de Tribolet N: Immunobiologie de l'astrocyte normal et tumoral. Rev Neurol 143:711–721, 1987 Pulver M, Zuber P, de Tribolet N: Immunobiologie de l'astrocyte normal et tumoral. Rev Neurol 143:711–721, 1987

Pulver M, Zuber P, de Tribolet N: Immunobiologie de l'astrocyte normal et tumoral. Rev Neurol 143:711–721, 1987Pulver M, Zuber P, de Tribolet N: Immunobiologie de l'astrocyte normal et tumoral. Rev Neurol 143:711–721, 1987)| false
• Search Google Scholar
• Export Citation

Roberts AB, & Sporn MB: The transforming growth factors-β, in Sporn MB, & Roberts AB (eds): Handbook of Experimental Pharmacology: Peptide Growth Factors and Their Receptors, Vol 95. Heidelberg: Springer-Verlag, 1990, pp 419–472 Roberts AB, Sporn MB: The transforming growth factors-β, in Sporn MB, Roberts AB (eds): Handbook of Experimental Pharmacology: Peptide Growth Factors and Their Receptors, Vol 95. Heidelberg: Springer-Verlag, 1990, pp 419–472

Roberts AB, Sporn MB: The transforming growth factors-β, in Sporn MB, Roberts AB (eds): Handbook of Experimental Pharmacology: Peptide Growth Factors and Their Receptors, Vol 95. Heidelberg: Springer-Verlag, 1990, pp 419–472Roberts AB, Sporn MB: The transforming growth factors-β, in Sporn MB, Roberts AB (eds): Handbook of Experimental Pharmacology: Peptide Growth Factors and Their Receptors, Vol 95. Heidelberg: Springer-Verlag, 1990, pp 419–472)| false
• Search Google Scholar
• Export Citation

Roberts AB, , Sporn MB, & Assoian RK, et al: Transforming growth factor type β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 83:4167–4171, 1986 Roberts AB, Sporn MB, Assoian RK, et al: Transforming growth factor type β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 83:4167–4171, 1986

Roberts AB, Sporn MB, Assoian RK, et al: Transforming growth factor type β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 83:4167–4171, 1986Roberts AB, Sporn MB, Assoian RK, et al: Transforming growth factor type β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 83:4167–4171, 1986)| false
• Search Google Scholar
• Export Citation

Rook AH, , Kehrl JH, & Wakefield LM, et al: Effects of transforming growth factor β on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. J Immunol 136:3916–3920, 1986 Rook AH, Kehrl JH, Wakefield LM, et al: Effects of transforming growth factor β on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. J Immunol 136:3916–3920, 1986

Rook AH, Kehrl JH, Wakefield LM, et al: Effects of transforming growth factor β on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. J Immunol 136:3916–3920, 1986Rook AH, Kehrl JH, Wakefield LM, et al: Effects of transforming growth factor β on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. J Immunol 136:3916–3920, 1986)| false
• Search Google Scholar
• Export Citation

Rossi ML, , Hughes JT, & Esiri MM, et al: Immunohistological study of mononuclear cell infiltrate in malignant gliomas. Acta Neuropathol 74:269–277, 1987 Rossi ML, Hughes JT, Esiri MM, et al: Immunohistological study of mononuclear cell infiltrate in malignant gliomas. Acta Neuropathol 74:269–277, 1987

Rossi ML, Hughes JT, Esiri MM, et al: Immunohistological study of mononuclear cell infiltrate in malignant gliomas. Acta Neuropathol 74:269–277, 1987Rossi ML, Hughes JT, Esiri MM, et al: Immunohistological study of mononuclear cell infiltrate in malignant gliomas. Acta Neuropathol 74:269–277, 1987)| false
• Search Google Scholar
• Export Citation

Roszman TL, & Brooks WH: Immunobiology of primary intracranial tumours. III. Demonstration of a qualitative lymphocyte abnormality in patients with primary brain tumours. Clin Exp Immunol 39:395–402, 1980 Roszman TL, Brooks WH: Immunobiology of primary intracranial tumours. III. Demonstration of a qualitative lymphocyte abnormality in patients with primary brain tumours. Clin Exp Immunol 39:395–402, 1980

Roszman TL, Brooks WH: Immunobiology of primary intracranial tumours. III. Demonstration of a qualitative lymphocyte abnormality in patients with primary brain tumours. Clin Exp Immunol 39:395–402, 1980Roszman TL, Brooks WH: Immunobiology of primary intracranial tumours. III. Demonstration of a qualitative lymphocyte abnormality in patients with primary brain tumours. Clin Exp Immunol 39:395–402, 1980)| false
• Search Google Scholar
• Export Citation

Schwyzer M, & Fontana A: Partial purification and biochemical characterization of a T cell suppressor factor produced by human glioblastoma cells. J Immunol 134:1003–1009, 1985 Schwyzer M, Fontana A: Partial purification and biochemical characterization of a T cell suppressor factor produced by human glioblastoma cells. J Immunol 134:1003–1009, 1985

Schwyzer M, Fontana A: Partial purification and biochemical characterization of a T cell suppressor factor produced by human glioblastoma cells. J Immunol 134:1003–1009, 1985Schwyzer M, Fontana A: Partial purification and biochemical characterization of a T cell suppressor factor produced by human glioblastoma cells. J Immunol 134:1003–1009, 1985)| false
• Search Google Scholar
• Export Citation

Thomas DGT, , Lannigan CB, & Behan PO, et al: Impaired cell-mediated immunity in human brain tumours. Lancet 1:1389–1390, 1975 (Letter) Thomas DGT, Lannigan CB, Behan PO, et al: Impaired cell-mediated immunity in human brain tumours. Lancet 1:1389–1390, 1975 (Letter)

Thomas DGT, Lannigan CB, Behan PO, et al: Impaired cell-mediated immunity in human brain tumours. Lancet 1:1389–1390, 1975 (Letter)Thomas DGT, Lannigan CB, Behan PO, et al: Impaired cell-mediated immunity in human brain tumours. Lancet 1:1389–1390, 1975 (Letter))| false
• Search Google Scholar
• Export Citation

Tsunawaki S, , Sporn M, & Ding A, et al: Deactivation of macrophages by transforming growth factor-β. Nature 334:260–262, 1988 (Letter) Tsunawaki S, Sporn M, Ding A, et al: Deactivation of macrophages by transforming growth factor-β. Nature 334:260–262, 1988 (Letter)

Tsunawaki S, Sporn M, Ding A, et al: Deactivation of macrophages by transforming growth factor-β. Nature 334:260–262, 1988 (Letter)Tsunawaki S, Sporn M, Ding A, et al: Deactivation of macrophages by transforming growth factor-β. Nature 334:260–262, 1988 (Letter))| false
• Search Google Scholar
• Export Citation

Woodworth CD, , Notario V, & Di Paolo JA, et al: Transforming growth factors β1 and 2 transcriptionally regulate human papillomavirus (HPV) type 16 early gene expression in HPV-immortalized human genital epithelial cells. J Virol 64:4767–4775, 1990 Woodworth CD, Notario V, Di Paolo JA, et al: Transforming growth factors β1 and 2 transcriptionally regulate human papillomavirus (HPV) type 16 early gene expression in HPV-immortalized human genital epithelial cells. J Virol 64:4767–4775, 1990

Woodworth CD, Notario V, Di Paolo JA, et al: Transforming growth factors β1 and 2 transcriptionally regulate human papillomavirus (HPV) type 16 early gene expression in HPV-immortalized human genital epithelial cells. J Virol 64:4767–4775, 1990Woodworth CD, Notario V, Di Paolo JA, et al: Transforming growth factors β1 and 2 transcriptionally regulate human papillomavirus (HPV) type 16 early gene expression in HPV-immortalized human genital epithelial cells. J Virol 64:4767–4775, 1990)| false
• Search Google Scholar
• Export Citation

Wrann M, , Bodmer S, & de Martin R, et al: T cell suppressor factor from human glioblastoma cells is a 12.5-kd protein closely related to transforming growth factor-β. EMBO J 6:1633–1636, 1987 Wrann M, Bodmer S, de Martin R, et al: T cell suppressor factor from human glioblastoma cells is a 12.5-kd protein closely related to transforming growth factor-β. EMBO J 6:1633–1636, 1987

Wrann M, Bodmer S, de Martin R, et al: T cell suppressor factor from human glioblastoma cells is a 12.5-kd protein closely related to transforming growth factor-β. EMBO J 6:1633–1636, 1987Wrann M, Bodmer S, de Martin R, et al: T cell suppressor factor from human glioblastoma cells is a 12.5-kd protein closely related to transforming growth factor-β. EMBO J 6:1633–1636, 1987)| false
• Search Google Scholar
• Export Citation

Zuber P, , Kuppner MC, & de Tribolet N: Transforming growth factor-β2 down-regulates HLA-DR antigen expression on human malignant glioma cells. Eur J Immunol 18:1623–1626, 1988 Zuber P, Kuppner MC, de Tribolet N: Transforming growth factor-β2 down-regulates HLA-DR antigen expression on human malignant glioma cells. Eur J Immunol 18:1623–1626, 1988

Zuber P, Kuppner MC, de Tribolet N: Transforming growth factor-β2 down-regulates HLA-DR antigen expression on human malignant glioma cells. Eur J Immunol 18:1623–1626, 1988Zuber P, Kuppner MC, de Tribolet N: Transforming growth factor-β2 down-regulates HLA-DR antigen expression on human malignant glioma cells. Eur J Immunol 18:1623–1626, 1988)| false
• Search Google Scholar
• Export Citation

Zülch KJ: Histological typing of tumors of the central nervous system. International Histological Classification of Tumors. No. 21. Geneva: World Health Organization, 1979 Zülch KJ: Histological typing of tumors of the central nervous system. International Histological Classification of Tumors. No. 21. Geneva: World Health Organization, 1979

Zülch KJ: Histological typing of tumors of the central nervous system. International Histological Classification of Tumors. No. 21. Geneva: World Health Organization, 1979Zülch KJ: Histological typing of tumors of the central nervous system. International Histological Classification of Tumors. No. 21. Geneva: World Health Organization, 1979)| false
• Search Google Scholar
• Export Citation